This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Ince, P., Appleton, D., Finney, K. et al. Verapamil increases the sensitivity of primary human colorectal carcinoma tissue to vincristine. Br J Cancer 53, 137–139 (1986). https://doi.org/10.1038/bjc.1986.19
Issue Date:
DOI: https://doi.org/10.1038/bjc.1986.19
- Springer Nature Limited
This article is cited by
-
Design, Development, In Silico, and In Vitro Characterization of Camptothecin-Loaded Mixed Micelles: In Vitro Testing of Verapamil and Ranolazine for Repurposing as Coadjuvant Therapy in Cancer
Journal of Pharmaceutical Innovation (2023)
-
Incorporation of drug efflux inhibitor and chemotherapeutic agent into an inorganic/organic platform for the effective treatment of multidrug resistant breast cancer
Journal of Nanobiotechnology (2019)
-
Organ culture as a model for investigating the effects of antimetabolites and nucleoside transport inhibitors on rodent colonic mucosa
In Vitro Cellular & Developmental Biology - Animal (1991)
-
Verapamil and cyclosporin a sensitize human kidney tumor cells to vincristine in absence of membrane P-glycoprotein and without apparent changes in the cytoplasmic free Ca2+ concentration
Bioscience Reports (1990)
-
Expression of verapamil hypersensitivity in multidrug-resistant cells grown as multicellular spheroids
Cancer Chemotherapy and Pharmacology (1990)